ImmunityBio Class Action Lawsuit Claims Investors Were Misled About Cancer Drug Approval Risks
Yes, investors in ImmunityBio are claiming they were misled about the approval and efficacy of the company’s cancer drug ANKTIVA.
Yes, investors in ImmunityBio are claiming they were misled about the approval and efficacy of the company’s cancer drug ANKTIVA.
Driven Brands Holdings Inc. concealed significant accounting errors and internal control failures from investors, leading to a major securities fraud…
Vital Farms, Inc. faces a class action lawsuit alleging that the company and its senior executives made materially false and misleading statements about a…
monday.com Ltd., a publicly traded work management software company trading on NASDAQ under the ticker MNDY, faces a federal class action lawsuit alleging…
Yes, ChampionX investors are claiming they were misled about material information during a critical period when company executives were repurchasing…
Kalshi, a federally regulated prediction market platform, faces mounting class action lawsuits across multiple states claiming that its betting mechanics…
A class action lawsuit filed on May 4, 2026, accuses Cento Fine Foods, a New Jersey-based Italian food distributor, of committing “tomato fraud” by…
A medical device recall lawsuit is a legal claim brought by patients or their families against manufacturers of medical devices that fail to perform…
A defective medical device lawsuit is a legal claim filed against a manufacturer when a medical device causes injury, fails to function properly, or poses…
Aromatherapy burn lawsuits remain a relatively fragmented area of product liability litigation, with cases stemming from essential oil products that cause…